|
||||||||
What do you want to do?
|
|||||||
BCCA News Update - 4 May 2020
Dear BCCA Member Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 Many centres around the UK are now reporting an increasing number of children presenting with a multi system inflammatory syndrome temporally associated with COVID-19. This syndrome shares common features with other paediatric inflammatory conditions including: Kawasaki disease, staphylococcal and streptococcal toxic shock syndromes, bacterial sepsis and macrophage activation syndromes. Children typically present with persistent fever, inflammation (neutrophilia, elevated CRP and lymphopaenia) and evidence of single or multi-organ dysfunction. The Royal College of Paediatrics and Child Health has produced guidance with expert input from colleagues in infectious disease, intensive care, cardiology and rheumatology. Please find below a link to the RCPCH guidance. A British Paediatric Surveillance Unit (BPSU) study is due to start soon - please notify them of any cases when the data collection opens. We are highlighting a need for a raised awareness of this syndrome, which is now leading to significant numbers of children requiring hospital admission, including intensive care. Cardiological input is important for the assessment and management of myocarditis, valvulitis, pericardial effusion and coronary artery dilatation. The multi-disciplinary approach to management is outlined in the RCPCH guidance. Guidance can be found at: https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 and is attached here. BCCA will keep members updated as further information and guidance becomes available. BCCA 4 May 2020
|
||
|
|
||